Eyconis
CA - Redwood CityBiotechnology
Focus: Eyconis is a newly public (2024) biotech company headquartered in Redwood City, CA focused on developing novel, best-in-class therapeutics for ophthalmology, particularly eye diseases. The company is in early-stage clinical development with a single Phase 1/2 program.
Profile data last refreshed 17h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Eyconis?
AI assessmentHigh-risk, high-reward fit for early-career scientists willing to bet on a nascent ophthalmology play; not suitable for those prioritizing stability or diverse portfolio upside.
Why Work Here
- Ground-floor opportunity at a newly public ophthalmology-focused biotech with a validated founding thesis around eye disease therapeutics.
- Early-stage pipeline with potential for significant scientific contribution—currently executing first-in-human trial for EYC-0305 in wet AMD (Aug 2026).
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1/2
Clinical Trials (1)
NCT07587515Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
Phase 1/2Help build intelligence for Eyconis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.